¼¼°èÀÇ ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀå
Sleep Apnea Diagnostic Systems
»óǰÄÚµå : 1757843
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 270 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 170¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 112¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGR 7.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 170¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼ö¸é´Ù¿ø°Ë»ç ÀåÄ¡´Â CAGR 6.7%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 106¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ ½ºÅ©¸®´× ÀåÄ¡ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 31¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 11.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡ 31¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 35¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 11.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.6%¿Í 6.9%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.7%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ '¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ' ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¼ö¸é¹«È£ÈíÁõ Áø´ÜÀÌ Àü ¼¼°è °Ç°­ÀÇ ¿ì¼±¼øÀ§°¡ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

¼ö¸é¹«È£ÈíÁõÈıºÀº Àü ¼¼°è 10¾ï ¸í ÀÌ»óÀÌ ¾Î°í ÀÖ´Â ¸¸¼º ¹ÌÁø´Ü ÁúȯÀ¸·Î ½ÉÇ÷°ü Áúȯ, ºñ¸¸, ´ç´¢, ¿ì¿ïÁõ, ÀÎÁö±â´É Àå¾Ö¿ÍÀÇ °­ÇÑ »ó°ü°ü°è·Î ÀÎÇØ °øÁߺ¸°ÇÀÇ Å« °ü½É»ç·Î ¶°¿À¸£°í ÀÖ½À´Ï´Ù. °¡Àå ÈçÇÑ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA)Àº ¼ö¸é Áß »ó±âµµ ÇãÅ»ÀÌ ¹Ýº¹ÀûÀ¸·Î ¹ß»ýÇÏ¿© °£ÇæÀûÀÎ »ê¼Ò °áÇÌÀ» À¯¹ßÇÏ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ¿¡ µû¸¥ °Ç°­ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀÓ»óÀû ¼ö¿ä¿Í ¼ÒºñÀÚÀÇ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿ª»çÀûÀ¸·Î Áø´ÜÀº ½ÇÇè½Ç ³» ¼ö¸é´Ù¿ø°Ë»ç(PSG)¿¡ Å©°Ô ÀÇÁ¸ÇØ ¿ÔÀ¸¸ç, ÀÌ °Ë»ç´Â ±Ý°ú¿ÁÁ¶·Î ¿©°ÜÁ® ¿ÔÁö¸¸ ¸¹Àº ÀÚ¿øÀÌ ¼Ò¿äµÇ´Â °úÁ¤À̾ú½À´Ï´Ù. ±×·¯³ª ÀϺΠ±¹°¡¿¡¼­´Â 80%¿¡ °¡±î¿î ¹ÌÁø´Ü »ç·Ê°¡ Á¸ÀçÇϱ⠶§¹®¿¡ º¸´Ù Á¢±Ù¼ºÀÌ ³ô°í È®Àå °¡´ÉÇÏ¸ç ºñ¿ë È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ­, ºñ¸¸À² Áõ°¡, »ýȰ½À°ü ½ºÆ®·¹½º°¡ Àü ¼¼°èÀûÀ¸·Î ¼ö¸éÀå¾ÖÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ´Â ¸¸Å­ ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛÀº ¼ö¸é °Ë»ç½Ç»Ó¸¸ ¾Æ´Ï¶ó 1Â÷ Áø·á ¹× ÀçÅà ȯ°æ¿¡¼­µµ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. Àü±¹ÀûÀÎ ¼ö¸é °Ç°­ ÀÌ´Ï¼ÅÆ¼ºê¿Í °í¿ëÁÖ°¡ ÈÄ¿øÇÏ´Â À£´Ï½º ÇÁ·Î±×·¥µµ º¸´Ù ±¤¹üÀ§ÇÑ °ËÁøÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¼ö¸éÀå¾Ö°¡ ¸¸¼ºÁúȯ °ü¸®ÀÇ µ¿¹ÝÁúȯÀ¸·Î ÀνĵǸ鼭 ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀº Æ´»õ Àü¹®ºÐ¾ß¿¡¼­ Àϼ± ¿¹¹æÀÇÇÐÀ¸·Î ÀüȯµÇ°í ÀÖÀ¸¸ç, Àü ¼¼°è ¼ö¸éÀÇ·á Àü·«À» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

±â¼ú°ú Ȩ ±â¹Ý Çõ½ÅÀº ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº ½Ã½ºÅÛÀ» º¸´Ù ½º¸¶Æ®Çϰí, ÈÞ´ë °¡´ÉÇϸç, ȯÀÚ Áß½ÉÀ¸·Î ¸¸µé¾î ¼ö¸é¹«È£ÈíÁõ Áø´Ü »óȲÀ» ±Ùº»ÀûÀ¸·Î Çö´ëÈ­Çϰí ÀÖ½À´Ï´Ù. ÀÓ»ó ÇöÀå¿¡¼­ ¼öÇàµÇ´Â ÀüÅëÀûÀÎ ¾ß°£ PSG °Ë»ç´Â ÀÌÁ¦ ÷´Ü ÀçÅà ¼ö¸é °Ë»ç(HST) ÀåÄ¡·Î º¸¿ÏµÇ°í Á¾Á¾ ´ëüµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÈÞ´ë¿ë Áø´Ü ½Ã½ºÅÛÀº ±â·ù, »ê¼Ò Æ÷È­µµ, ½É¹Ú¼ö, È£Èí ³ë·Â, üÀ§ µîÀÇ ¸Å°³ º¯¼ö¸¦ º¸´Ù Á¤È®ÇÏ°Ô ÃøÁ¤ÇÕ´Ï´Ù. ¹«¼± ¼¾¼­, ºí·çÅõ½º ¿¬°á, Ŭ¶ó¿ìµå ±â¹Ý µ¥ÀÌÅÍ Àü¼ÛÀ» ÅëÇØ ¿ø°ÝÁö¿¡¼­ ¼ö¸é µ¥ÀÌÅ͸¦ ¼öÁýÇÏ°í ½Ç½Ã°£À¸·Î ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ë·®ÀÇ ¼ö¸é µ¥ÀÌÅ͸¦ ÇØ¼®ÇÏ°í ¹«È£ÈíÁõ À̺¥Æ®¸¦ ÀÓ»ó°ú °¡±î¿î Á¤È®µµ·Î °¨ÁöÇϱâ À§ÇØ AI¿Í ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ´Ùä³Î ¿þ¾î·¯ºí ¹× ½º¸¶Æ® ¼¶À¯´Â ¿©·¯ ³¯ ¹ã µ¿¾È ´«¿¡ ¶çÁö ¾Ê°Ô ¼ö¸é ÆÐÅÏÀ» ÃßÀûÇϰí Áø´Ü Á¤È®µµ¸¦ ³ôÀ̱â À§ÇØ ¿¬±¸µÇ°í ÀÖÀ¸¸ç, FDA ½ÂÀÎ ÁÖº¯±â±â¿Í ÅëÇÕµÈ ½º¸¶Æ®Æù ¾ÛÀº °ø½ÄÀûÀÎ ¼ö¸é °Ë»ç Àü¿¡ ¿¹ºñ °Ë»ç ¹× ¼±º°À» ÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ÀÇ·á Ç÷§ÆûÀº ¿ø°Ý Áø·á, µðÁöÅРó¹æ, ÅëÇÕ Áø·á °æ·Î¸¦ ÅëÇØ Áø´Ü ¹× Ä¡·á ½ÃÀÛÀ» °£¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÚµ¿È­µÈ äÁ¡ ¹× Ŭ¶ó¿ìµå ±â¹Ý ºÐ¼®Àº ¼ö¸é ¼¾ÅÍÀÇ ¼Ò¿ä ½Ã°£À» ´ÜÃàÇϰí ó¸® ´É·ÂÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû µµ¾àÀº ¼ö¸é¹«È£ÈíÁõ ½Ã½ºÅÛÀÇ Áø´Ü ¹üÀ§¸¦ È®ÀåÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ÀÓ»ó ¹× ºñÀÓ»ó ȯ°æ¿¡¼­ ȯÀÚÀÇ ¼øÀÀµµ, Æí¾ÈÇÔ, Ä¡·áÀÇ ¿¬¼Ó¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¼ö¸é¹«È£ÈíÁõ °Ë»ç È®´ë ½ÃÀå ¼ö¿ä¿Í ÇコÄÉ¾î º¯È­¶õ?

¸î °¡Áö ÁøÈ­ÇÏ´Â ÇコÄÉ¾î Æ®·»µå°¡ ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛÀÇ ±¤¹üÀ§ÇÑ ½ÃÀå µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ °íÇ÷¾Ð, ºñ¸¸, ½É¹æ¼¼µ¿, 2Çü ´ç´¢º´°ú °°Àº °íÀ§Ç豺¿¡¼­´Â ȯÀÚ¿Í ÀÇ»çÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¶±â °ËÁøÀÌ ´õ¿í Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. º¸Çè»ç ¹× °øÁߺ¸°Ç ´ç±¹Àº ºñ¿ë È¿À²ÀûÀÎ °Ë»ç½Ç PSGÀÇ ´ë¾ÈÀ¸·Î ÀçÅà Áø´Ü °Ë»ç¿¡ ´ëÇÑ È¯±ÞÀ» ´Ã·Á ȯÀÚ Á¢±Ù¼ºÀ» È®´ëÇϰí ÀÖ½À´Ï´Ù. ±â¾÷ À£´Ï½º ºÐ¾ß¿¡¼­´Â ´ë±â¾÷µéÀÌ ¼ö¸é ÀǷḦ »ê¾÷ ÀÇÇÐ ¹× ¼º°ú ÃÖÀûÈ­ ÇÁ·Î±×·¥¿¡ ÅëÇÕÇÏ¿© ±âÁ¸°ú´Â ´Ù¸¥ »õ·Î¿î °Ë»ç ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¼Ò¾Æ ¼ö¸é¹«È£ÈíÁõÀº Á¾Á¾ ¹ß´Þ ¹®Á¦ ¹× Çൿ Àå¾Ö¿Í °ü·ÃÀÌ ÀÖ¾î ¼Ò¾Æ Àü¿ë Áø´Ü µµ±¸ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀº Ãʱâ Áõ»óÀÌ °¡Àå ¸ÕÀú °üÂûµÇ´Â Ä¡°ú³ª À̺ñÀÎÈİú Áø·á¼Ò¿¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ½ºÅ¸Æ®¾÷µéÀº ¼ÒºñÀÚµéÀ» À§ÇÑ ¿þ¾î·¯ºí ¼Ö·ç¼Ç°ú AI ±â¹Ý ¾ÛÀ¸·Î ½ÃÀå¿¡ ÁøÀÔÇÏ¿© ÀÚ°¢ Áõ»ó°ú Á¤½Ä Áø´ÜÀÇ °£±ØÀ» ¸Þ¿ì°í ÀÖ½À´Ï´Ù. ÇÑÆí, º´¿ø°ú ¼ö¸é ¿¬±¸¼Ò´Â ½ÇÇè½Ç ³» PSG¿Í ÈÞ´ë¿ë HST¸¦ °áÇÕÇÑ ÇÏÀ̺긮µå ¸ðµ¨À» äÅÃÇÏ¿© ¾÷¹« È¿À²¼ºÀ» °³¼±Çϰí ÀÖÀ¸¸ç, Äڷγª19´Â ¿ø°Ý Áø´ÜÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­ÇÏ¿© ÀÇ·á ÀÎÇÁ¶ó¸¦ ¿ø°Ý ¼ö¸é ¼Ö·ç¼ÇÀ¸·Î ¿µ±¸ÀûÀ¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÓ»óÀû ±ä±Þ¼º, ÀǷẸÇè °³Çõ, ȯÀÚ ±ÇÇÑ ºÎ¿©ÀÇ ¼ö·ÅÀº ¼ö¸é¹«È£ÈíÁõ °Ë»çÀÇ º¸±Þ°ú ´Ù¾çÈ­¿¡ À¯¸®ÇÏ°Ô ½ÃÀå ¿ªÇÐÀ» À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

¼¼°è ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú µµÀÔ, ÇコÄɾîÀÇ ¹ßÀü, ÃÖÁ¾ »ç¿ëÀÚ Çൿ°ú ¿¬°èµÈ ¸î °¡Áö Àß Á¤ÀÇµÈ »óÈ£ ¿¬°üµÈ Èû¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, ºñ¸¸, °í·ÉÈ­, ÁÂ½Ä »ýȰ½À°ü°ú °°Àº ¼¼°èÀûÀÎ Ãß¼¼·Î ÀÎÇØ ¼ö¸é¹«È£ÈíÁõ(ƯÈ÷ OSA)ÀÇ À¯º´·üÀÌ Áõ°¡Çϰí Áø´Ü ´ë»ó Àα¸°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. µÑ°, °¡Á¤¿ë ¼ö¸é °Ë»ç ±â±â, ¿þ¾î·¯ºí ¼¾¼­, AI ±â¹Ý Áø´Ü Ç÷§Æû µîÀÇ ±â¼ú ¹ßÀüÀ¸·Î Áø´ÜÀÌ º¸´Ù Ä£¼÷Çϰí, Àú·ÅÇϸç, ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ È®Àå °¡´ÉÇØÁ³½À´Ï´Ù. ¼Â°, ÀÇ·á Á¤Ã¥ °³Çõ°ú ¼ö¸é¹«È£ÈíÁõÀÌ ¸¸¼ºÁúȯÀÇ À§Çè¿äÀÎÀ̶ó´Â ÁöºÒÀÚÀÇ ÀνÄÀ¸·Î ÀÎÇØ ƯÈ÷ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­ Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ º¸Çè±Þ¿© ¹üÀ§°¡ °³¼±µÇ°í ÀÖ½À´Ï´Ù. ³Ý°, ¼ö¸é Áø´ÜÀÌ º¸´Ù ±¤¹üÀ§ÇÑ ¿ø°Ý ÀÇ·á ¹× µðÁöÅÐ °Ç°­ »ýŰ迡 ÅëÇյǸ鼭 ¿öÅ©Ç÷ο찡 °£¼ÒÈ­µÇ°í ȯÀÚ µµ´Þ ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ´Ù¼¸Â°, Ä¡°ú Áø·á¼Ò, »ê¾÷ º¸°Ç ÇÁ·Î±×·¥, ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å À£ºù Ç÷§Æû µî ±âÁ¸°ú´Â ´Ù¸¥ ä³Î ¼ö¿ä Áõ°¡·Î º´¿ø ¼ö¸é °Ë»ç½Ç ¿Ü ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¿©¼¸Â°, ÀÇ»çÀÇ ÀÎ½Ä Á¦°í¿Í ´ÙÇÐÁ¦Àû Çù·ÂÀ¸·Î Á¶±â °ËÁø ¹× Áø´ÜÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. Àϰö°, ÈÞ´ë¿ë ±â±â ¹× AI Áö¿ø ±â±âÀÇ ºü¸¥ ±â¼ú Çõ½Å ÁÖ±â¿Í ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ¸·Î ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷ ½ÃÀå ÁøÀÔ À庮ÀÌ ³·¾ÆÁö°í Á¦Ç° ´Ù¾ç¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¼ö¸é °Ç°­¿¡ ´ëÇÑ ÀϹÝÀûÀÎ °ü½É»Ó¸¸ ¾Æ´Ï¶ó ÀÌ·¯ÇÑ ±â¼ú ¹× ÇコÄɾ ƯȭµÈ ÃËÁø¿äÀÎÀÌ ¼¼°è ¼ö¸é¹«È£ÈíÁõ Áø´Ü ½Ã½ºÅÛ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ °í¼ºÀå ¸ð¸àÅÒÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¼ö¸é´Ù¿ø°Ë»ç ÀåÄ¡, ¼ö¸é¹«È£ÈíÁõ ½ºÅ©¸®´× ÀåÄ¡, ¼ö¸é´Ù¿ø°Ë»ç ¸ð´ÏÅ͸µ ÀåÄ¡);ÃÖÁ¾»ç¿ëÀÚ(ÀçÅÃÄ¡·á, º´¿ø, ¼ö¸é ¼¾ÅÍ£¦Å¬¸®´Ð)

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÃÑ 33°³»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLMÀ̳ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è µµ¸ÞÀÎ Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Sleep Apnea Diagnostic Systems Market to Reach US$17.0 Billion by 2030

The global market for Sleep Apnea Diagnostic Systems estimated at US$11.2 Billion in the year 2024, is expected to reach US$17.0 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Polysomnography Devices, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth in the Sleep Apnea Screening Devices segment is estimated at 8.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.1 Billion While China is Forecast to Grow at 11.0% CAGR

The Sleep Apnea Diagnostic Systems market in the U.S. is estimated at US$3.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global "Sleep Apnea Diagnostic Systems" Market - Key Trends & Drivers Summarized

Why Is The Diagnosis Of Sleep Apnea Becoming A Global Health Priority?

Sleep apnea - a chronic, underdiagnosed disorder affecting over 1 billion people globally - has emerged as a major public health concern due to its strong correlation with cardiovascular disease, obesity, diabetes, depression, and impaired cognitive function. Obstructive Sleep Apnea (OSA), the most prevalent form, is characterized by repeated upper airway collapse during sleep, leading to intermittent oxygen deprivation. Increasing awareness about the health risks associated with untreated sleep apnea is driving both clinical demand and consumer interest in early diagnosis. Historically, diagnosis relied heavily on in-lab polysomnography (PSG), a gold-standard but resource-intensive process. However, the high prevalence of undiagnosed cases - nearly 80% in some countries - has exposed the need for more accessible, scalable, and cost-effective diagnostic solutions. With aging populations, rising obesity rates, and lifestyle stressors contributing to sleep disorders worldwide, sleep apnea diagnostic systems are becoming essential tools not only in sleep labs but also in primary care and home-based environments. National sleep health initiatives and employer-sponsored wellness programs are also promoting broader screening. As sleep disorders gain recognition as a comorbidity driver in chronic disease management, sleep apnea diagnostics are shifting from niche specialty to frontline preventive care - reshaping global sleep medicine strategies.

How Are Technology And Home-Based Innovations Transforming Sleep Apnea Diagnosis?

Technological innovation is radically modernizing the landscape of sleep apnea diagnostics by making systems smarter, portable, and patient-centric. Traditional full-night PSG studies conducted in clinical settings are now complemented - and often replaced - by advanced home sleep testing (HST) devices. These portable diagnostic systems measure parameters like airflow, oxygen saturation, heart rate, respiratory effort, and body position with increasing accuracy. Wireless sensors, Bluetooth connectivity, and cloud-based data transmission allow sleep data to be collected remotely and analyzed in real time. AI and machine learning algorithms are being employed to interpret large volumes of sleep data and detect apnea events with near-clinical precision. Multi-channel wearables and smart textiles are also being explored to track sleep patterns unobtrusively over multiple nights, enhancing diagnostic accuracy. Smartphone apps integrated with FDA-approved peripheral devices enable preliminary screening and triaging before formal sleep studies. Furthermore, telehealth platforms now allow for remote consultations, digital prescriptions, and integrated care pathways - streamlining diagnosis and treatment initiation. Automated scoring and cloud-based analytics are reducing turnaround time and improving throughput in sleep centers. These technological leaps are not only increasing the diagnostic reach of sleep apnea systems but also improving patient compliance, comfort, and continuity of care across both clinical and non-clinical environments.

What Market Demands And Healthcare Shifts Are Expanding Sleep Apnea Testing?

Several evolving healthcare trends are fueling broader market adoption of sleep apnea diagnostic systems. Rising awareness among patients and physicians is prompting earlier screening, especially in high-risk groups such as individuals with hypertension, obesity, atrial fibrillation, and type 2 diabetes. Insurance providers and public health authorities are increasingly reimbursing home-based diagnostic tests as cost-effective alternatives to lab-based PSG, broadening patient access. In the corporate wellness space, large employers are integrating sleep health into occupational medicine and performance optimization programs, creating new non-traditional testing demand. Pediatric sleep apnea, often linked to developmental issues and behavioral disorders, is also a growing area of focus - driving the need for specialized diagnostic tools tailored to children. Sleep apnea diagnostics are also seeing rising uptake in dental practices and ENT clinics, where early signs are often first observed. Digital health startups are entering the market with consumer-friendly wearable solutions and AI-powered apps that bridge the gap between awareness and formal diagnosis. Hospitals and sleep labs, in turn, are adopting hybrid models that combine in-lab PSG with portable HST to improve operational efficiency. COVID-19 accelerated the adoption of remote diagnostics, permanently shifting healthcare infrastructure toward tele-sleep solutions. This convergence of clinical urgency, reimbursement reforms, and patient empowerment is reshaping the market dynamics in favor of widespread, diversified sleep apnea testing.

What Factors Are Driving The Growth Of The Sleep Apnea Diagnostic Systems Market Globally?

The growth in the sleep apnea diagnostic systems market is driven by several clearly defined and interrelated forces tied to technology adoption, healthcare evolution, and end-user behavior. First, the rising prevalence of sleep apnea - particularly OSA - due to global trends in obesity, aging, and sedentary lifestyles is expanding the target diagnostic population. Second, technological advancements in home sleep testing devices, wearable sensors, and AI-driven diagnostic platforms are making diagnosis more accessible, affordable, and scalable across diverse care settings. Third, healthcare policy reforms and payer recognition of sleep apnea as a chronic disease risk factor are improving reimbursement coverage for diagnostic procedures, especially in North America, Europe, and parts of Asia-Pacific. Fourth, the integration of sleep diagnostics into broader telemedicine and digital health ecosystems is streamlining workflows and increasing patient reach. Fifth, growing demand from non-traditional channels - such as dental clinics, occupational health programs, and direct-to-consumer wellness platforms - is broadening the market beyond hospital sleep labs. Sixth, increasing physician awareness and interdisciplinary collaboration are promoting earlier screening and diagnosis. Seventh, rapid innovation cycles and regulatory approvals for portable and AI-enabled devices are lowering market entry barriers for new players and expanding product diversity. Together, these technology- and healthcare-specific drivers - not just general interest in sleep wellness - are fueling sustained, high-growth momentum in the global sleep apnea diagnostic systems market.

SCOPE OF STUDY:

The report analyzes the Sleep Apnea Diagnostic Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Polysomnography Devices, Sleep Apnea Screening Devices, Actigraphy Monitoring Devices); End-User (Home Care Settings, Hospitals, Sleep Centers & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â